Navigation Links
Tylenol Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal Tylenol Liver Damage Litigation
Date:8/2/2014

New York, New York (PRWEB) August 02, 2014

Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who allegedly suffered severe liver damage due to the acetaminophen in over-the-counter Tylenol products continue to move forward in the U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. According to court documents, the litigation’s next Status Conference has been scheduled for Tuesday, August 19, 2014 at 10:00 a.m. The Court has directed Liaison Counsel to submit an agenda at least two business days prior to the conference. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“Our Firm has heard from a number of individuals who allegedly developed serious liver damage due to acetaminophen, the active ingredient in Tylenol-brand products. We are pleased that this proceeding is moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who allegedly suffered acetaminophen-induced liver damage resulting in hospitalization, liver transplantation, or death after ingesting a Tylenol product.

Tylenol Liver Damage Allegations
According to court documents, more than 140 Tylenol lawsuits have been filed in the federal litigation underway in the Eastern District of Pennsylvania. All of the claims accuse Johnson & Johnson and McNeil Consumer Healthcare of failing to provide adequate warnings regarding the association between the acetaminophen in Tylenol and liver damage. In many cases, Tylenol lawsuit plaintiffs claim that liver damage occurred even though the drugs were used in accordance with label directions.

According to a recent report published by The Philadelphia Inquirer, 78,000 people require emergency room care every year due to toxic reactions to acetaminophen. Such injuries also result in about 33,000 hospitalizations every year.* In 2011, the U.S. Food & Drug Administration (FDA) announced that it would limit the amount of acetaminophen in prescription medications to 325 mg per tablet. According to a notice posted on the Federal Register, the new limits went into affect on January 14, 2014.

The FDA has not imposed similar limits on the amount of acetaminophen in over-the-counter products. In August 2013, Bloomberg.com reported that over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits for prescription medications set by the FDA. That same month, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medication.**

Alleged victims of Tylenol and liver damage may be entitled to compensation for injury-related damages. To find out more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.

*articles.philly.com/2014-02-17/news/47382323_1_acetaminophen-poisoning-tylenol-maker-kate-trunk, Philadelphia Inquirer, February 17, 2014
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitclaims.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/tylenol-lawsuit/tylenol-liver-damage/prweb12067436.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tylenol Overdose Can Be Deadly for a Child
2. Tylenol Liver Damage Lawyers Are Now Available through Resource4thePeople
3. Tylenol Liver Failure Allegation Lawsuits Update: Resource4thePeople Reports Hearing to Consolidate Federal Cases Is Scheduled
4. Tylenol Liver Failure Allegation Claims Now Being Investigated by Resource4thePeople Attorneys
5. Experiencing existential dread? Tylenol may do the trick
6. Anxious about life? Tylenol may do the trick
7. Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center
8. Update on Alleged Tylenol Liver Failure Lawsuits from Resource4thePeople: Judge Selects Steering Committee in Multidistrict Litigation
9. Rottenstein Law Group LLP Announces New Tylenol Lawsuit Center
10. Latest Tylenol Liver Failure Lawsuit Allegations Report: Resource4thePeople Urges Consumers to Fully Inform Themselves about Liver Disease Danger Possibility
11. Tylenol Lawsuit News: New Jersey Supreme Court Refuses Multicounty Case Consolidation, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: